05/13
Headlines

BioTech

Healthcare Active Runners: Peregrine Pharmaceuticals (NASDAQ:PPHM), Bristol-Myers Squibb (NYSE:BMY), Abbott Laboratories (NYSE:ABT), Teva Pharmaceutical Industries (NYSE:TEVA)

Colin Pettis02 mins

Peregrine Pharmaceuticals (NASDAQ:PPHM) is scheduled to be releasing its Q314 earnings data on Friday, March 7th. Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was 47.64% in last session and finished the day at $2.82. Traded volume was 36.76million shares in the last session and the average volume of the stock remained 3.12million shares. The beta of the…

Read More

Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Insys Therapeutics (NASDAQ:INSY), NPS Pharmaceuticals (NASDAQ:NPSP), XOMA Corp (NASDAQ:XOMA)

Richard Atkins02 mins

The Rosen Law Firm, P.A. reminds purchasers of Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) between March 15, 2012 and January 9, 2014, inclusive (the “Class Period”) of the important Mach 17, 2014 lead plaintiff deadline in the class action seeking remedies under the federal securities laws. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock performance was -5.40% in last session…

Read More

Biotech Gainers: Arrowhead Research (NASDAQ:ARWR), DARA Biosciences (NASDAQ:DARA), Synthetic Biologics (NYSEMKT:SYN), Oncothyreon (NASDAQ:ONTY)

Mark DeFrance02 mins

Equities research analysts at Deutsche Bank assumed coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $45.00 price target on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was 24.46% in last session and finished the day…

Read More

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind Corporation (NASDAQ:MNKD), Synta Pharmaceuticals (NASDAQ:SNTA)

Kevin Long02 mins

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has been trading with ups and downs since the past few days, after the company announced better-than-expected results and its plans to partner for its flagship drug Iclusig. One of the major takeaway during the earnings call is Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s CEO Harvey Berger’s indication for potential partnership in Japan…

Read More

Stocks Making Noise After-Hours: Sanchez Energy (NYSE:SN), RigNet (NASDAQ:RNET), China New Borun Corp (NYSE:BORN)

Colin Pettis03 mins

Sanchez Energy (NYSE:SN) is higher in the after hours session after the company reported financial results for Q4 improved year-over-year, with record revenue growth, despite falling short of analysts’ expectations. Shares are up 1.22% at $29.90, with a 52-week range of $17.02 – $32.96. The independent oil and natural gas exploration and production company reported…

Read More

Peregrine Pharmaceuticals (NASDAQ:PPHM) Up 20% to 19-Month High; Agenus (NASDAQ:AGEN) Soars

Ryan Holtz03 mins

Peregrine Pharmaceuticals (NASDAQ:PPHM) is up nearly 20% and reached a 19-month high after the biopharmaceutical company said Wednesday that it will present data from three preclinical studies highlighting the immuno-oncology and anti-viral potential of phosphatidylserine (PS)-targeting antibodies. Results will be presented at two upcoming Keystone Symposia to be held March 9-13. Shares of Peregrine (NASDAQ:PPHM) are…

Read More